Revenues of BioCrude Technologies USA, Inc. from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
BioCrude Technologies USA, Inc. quarterly Revenues in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
  • BioCrude Technologies USA, Inc. Revenues for the quarter ending 30 Sep 2024 was $0.
Source SEC data
View on sec.gov
Revenues, Quarterly (USD)

BioCrude Technologies USA, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $0 $0 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q3 2023 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $0 $0 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q3 2022 $0 $0 01 Jul 2022 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $0 $0 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q3 2021 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $0 $0 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q3 2020 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $0 $0 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q3 2019 $0 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $0 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.